Your browser doesn't support javascript.
loading
Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.
González Martín, Antonio; Oza, Amit M; Embleton, Andrew C; Pfisterer, Jacobus; Ledermann, Jonathan A; Pujade-Lauraine, Eric; Kristensen, Gunnar; Bertrand, Monique A; Beale, Philip; Cervantes, Andrés; Kent, Emma; Kaplan, Richard S; Parmar, Mahesh K B; Scotto, Nana; Perren, Timothy J.
Afiliação
  • González Martín A; MD Anderson Cancer Center Spain, Madrid, Spain. Electronic address: agonzalezm@seom.org.
  • Oza AM; Princess Margaret Cancer Centre, University Health Network Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address: Amit.Oza@uhn.ca.
  • Embleton AC; Medical Research Council Clinical Trials Unit at University College London (UCL), 90 High Holborn, London WC1V 6LJ, UK. Electronic address: a.embleton@ucl.ac.uk.
  • Pfisterer J; Gynecologic Oncology Center, Herzog-Friedrich-Str. 21, 24103 Kiel, Germany. Electronic address: jacobus.pfisterer@googlemail.com.
  • Ledermann JA; UCL Cancer Institute, 90 Tottenham Court Road, London W1T 4TJ, UK. Electronic address: j.ledermann@ucl.ac.uk.
  • Pujade-Lauraine E; Hôpital Hôtel-Dieu, Assistance Publique - Hôpitaux de Paris, 1, Parvis Notre-Dame - Place Jean-Paul II, 75181 Paris CEDEX 04, France. Electronic address: epujade@arcagy.org.
  • Kristensen G; Department of Gynecologic Oncology and Institute for Cancer Genetics and Informatics, Radiumhospital, Oslo University Hospital, PO Box 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: gunnar.b.kristensen@gmail.com.
  • Bertrand MA; Western University and London Health Sciences Centre, 800 Commissioners Road East, PO Box 5010, Stn B, London, ON N6A 5W9, Canada. Electronic address: monique.bertrand@lhsc.on.ca.
  • Beale P; University of Sydney and Royal Prince Alfred Hospital, Level 6, Gloucester House, RPAH, Missenden Road, Camperdown, NSW 2050, Australia. Electronic address: Philip.Beale@health.nsw.gov.au.
  • Cervantes A; CIBERONC, Biomedical Research Institute INCLIVA, University of Valencia and Hospital Clínico de Valencia, Servicio de Hematología y Oncología Médica, Av. Blasco Ibáñez 17, 46010, Valencia, Spain. Electronic address: andres.cervantes@uv.es.
  • Kent E; Medical Research Council Clinical Trials Unit at University College London (UCL), 90 High Holborn, London WC1V 6LJ, UK. Electronic address: Emma.Kent@nice.org.uk.
  • Kaplan RS; Medical Research Council Clinical Trials Unit at University College London (UCL), 90 High Holborn, London WC1V 6LJ, UK. Electronic address: r.kaplan@ucl.ac.uk.
  • Parmar MKB; Medical Research Council Clinical Trials Unit at University College London (UCL), 90 High Holborn, London WC1V 6LJ, UK. Electronic address: m.parmar@ucl.ac.uk.
  • Scotto N; F. Hoffmann-La Roche Ltd, Building 1, Grenzacherstrasse 124, CH-4070 Basel, Switzerland. Electronic address: nana.scotto@roche.com.
  • Perren TJ; Leeds Institute for Cancer Medicine and Pathology, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK. Electronic address: t.j.perren@leeds.ac.uk.
Gynecol Oncol ; 152(1): 53-60, 2019 01.
Article em En | MEDLINE | ID: mdl-30449719
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2019 Tipo de documento: Article